Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.7620
-0.0060 (-0.78%)
Sep 2, 2026, 5:29 PM CET
Isofol Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | - | - | - | 0.72 | 12.8 | 22.41 |
| - | - | - | 0.72 | 12.8 | 22.41 | |
Revenue Growth | - | - | - | -94.37% | -42.89% | -39.63% |
Cost of Revenue | 40.16 | 40.16 | 38.73 | 35.14 | 143.71 | 196.71 |
Gross Profit | -40.16 | -40.16 | -38.73 | -34.42 | -130.92 | -174.31 |
Selling, General & Admin | 18.23 | 14.6 | 8.48 | 7.42 | 34.75 | 27.72 |
Other Operating Expenses | - | - | - | - | 1.81 | 0.84 |
Operating Expenses | 18.44 | 14.6 | 8.48 | 7.46 | 36.63 | 30.16 |
Operating Income | -58.6 | -54.76 | -47.22 | -41.88 | -167.54 | -204.47 |
Interest Expense | -0 | -0 | - | -0.01 | - | -0.17 |
Interest & Investment Income | 2.22 | 1.82 | 3.72 | 4.57 | 0.15 | 0.01 |
Currency Exchange Gain (Loss) | -0.24 | -1.22 | 0.01 | 0.24 | 3.79 | 0.84 |
Other Non Operating Income (Expenses) | -0 | - | - | - | 3.81 | 3.53 |
EBT Excluding Unusual Items | -56.63 | -54.17 | -43.49 | -37.07 | -159.79 | -200.25 |
Pretax Income | -56.63 | -54.17 | -43.49 | -37.07 | -159.79 | -200.25 |
Net Income | -56.63 | -54.17 | -43.49 | -37.07 | -159.79 | -200.25 |
Net Income to Common | -56.63 | -54.17 | -43.49 | -37.07 | -159.79 | -200.25 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 296 | 217 | 162 | 162 | 162 | 126 |
Shares Outstanding (Diluted) | 296 | 217 | 162 | 162 | 162 | 126 |
Shares Change | 86.24% | 34.49% | - | - | 28.55% | 104.40% |
EPS (Basic) | -0.19 | -0.25 | -0.27 | -0.23 | -0.99 | -1.59 |
EPS (Diluted) | -0.19 | -0.25 | -0.27 | -0.23 | -0.99 | -1.59 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -52.64 | -51.94 | -41.99 | -52.54 | -192.68 | -188.43 |
Free Cash Flow Per Share | -0.18 | -0.24 | -0.26 | -0.33 | -1.19 | -1.50 |
Operating Margin | - | - | - | -5808.04% | -1309.24% | -912.50% |
Profit Margin | - | - | - | -5141.61% | -1248.68% | -893.70% |
Free Cash Flow Margin | - | - | - | -7286.55% | -1505.66% | -840.94% |
EBITDA | - | -54.76 | -47.21 | -41.84 | -167.48 | -204.39 |
D&A For EBITDA | - | 0 | 0 | 0.04 | 0.07 | 0.08 |
EBIT | -58.6 | -54.76 | -47.22 | -41.88 | -167.54 | -204.47 |
Revenue as Reported | - | - | - | 0.72 | 12.8 | 22.41 |